Usefulness of lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction

Circulation Journal

Volumn 75, Issue 12, 2011, Pages 2847-2852

  Ikenaga, Hiroki ^a   Ishihara, Masaharu ^a   Inoue, Ichiro ^a   Kawagoe, Takuji ^a   Shimatani, Yuji ^a   Miura, Fumiharu ^a   Nakama, Yasuharu ^a   Dai, Kazuoki ^a   Otani, Takayuki ^a   Ejiri, Kentaro ^a   Oda, Nozomu ^a   Nakamura, Masayuki ^a   Miki, Takashi ^a  

^a HIROSHIMA CITY HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Lipoprotein (a); Prognosis; Revascularization

Indexed keywords

BIOLOGICAL MARKER; LIPOPROTEIN A;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TIME FACTORS;

EID: 82455210506     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0365     Document Type: Article

References (26)

1. Seed M, Ayres KL, Humphries SE, Miller GJ. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men. Am J Med 2001; 110: 22-27.
2. Terres W, Tatsis E, Pfalzer B, Beil FU, Beisiegel U, Hamm CW. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation 1995; 91: 948-950.
3. Liu AC, Lawn RM. Lipoprotein(a) and atherogenesis. Trends Cardiovasc Med 1994; 4: 40-44.
4. Maher VMG, Brown BG. Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol 1995; 6: 229-235.
5. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993; 260: 1655-1658.
6. Hartmann M, von Birgelen C, Mintz GS, Stoel MG, Eggebrecht H, Wieneke H, et al. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J Am Coll Cardiol 2006; 48: 446-452.
7. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation 1995; 91: 1403-1409.
8. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
9. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
10. Morita Y, Himeno H, Yakuwa H, Usui T. Serum lipoprotein(a) level and clinical coronary stenosis progression in patients with myocardial infarction. Circ J 2006; 70: 156-162.
11. Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 2007; 49: 1924-1930.
12. Fujino A, Watanabe T, Kunii H, Yamaguchi N, Yoshinari K, Watanabe Y, et al. Lipoprotein(a) is a potential coronary risk factor. Circ J 2000; 64: 51-56.
13. Igarashi Y, Aizawa Y, Satoh T, Konno T, Ojima K, Aizawa Y. Predictors of adverse long-term outcome in acute myocardial infarction patients undergoing primary percutaneous transluminal coronary angioplasty. Circ J 2003; 67: 605-611.
14. The Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke and nonvascular mortality. JAMA 2009; 302: 412-423.
15. Bennet A, Di Angelantonio E, Erqou S, Eiriksdottir G, Sigurdsson G, Woodward M, et al. Lipoprotein(a) levels and risk of Future coronary heart disease. Arch Intern Med 2008; 168: 598-608.
16. Berg K. A new serum type system in man: The lipoprotein system. Acta Pathol Microbiol Scand 1963; 59: 369-382.
17. Iwanaga Y, Miyazaki S. Heart failure, chronic kidney disease, and biomarkers. Circ J 2010; 74: 1274-1282.
18. Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, et al. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: Multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 2009; 73: 2110-2117.
19. Miyauchi K, Daida H. Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease: LDL-cholesterol: The lower, the better; is it true for Asians? (Pro) Circ J 2010; 74: 1718-1730.
20. Sakamoto T, Ogawa H. "Just make it lower" as an alternative strategy of lipid-lowering therapy with statins in Japanese patients: LDL-cholesterol: The lower, the better; is it true for Asians? (Con) Circ J 2010; 74: 1731-1741.
21. McKenney JM, Jones PH, Bays HE, Knopp RH, Kashyap ML, Ruoff GE, et al. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). Atherosclerosis 2007; 192: 432-437.
22. Armstrong VW, Schleef J, Thiery J, Muche R, Schuff-Werner P, Eisenhauer T, et al. Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): Kinetic analysis of the post-treatment return to baseline levels. Eur J Clin Invest 1989; 19: 235-240.
23. Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009; 361: 2113-2122.
24. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989; 78: 145-150.
25. Slunga L, Johnson O, Dahlen GH. Change in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin. Eur J Clin Pharmacol 1992; 43: 369-373.
26. Kawade M, Maeda S, Abe A, Yamashiro M. Alternations in plasma Lp(a) lipoprotein[Lp(a)] and acute phase proteins after surgical operation (abstract). Clin Chem 1984; 30: 941.